AMANDA COUCH: Open Payments
NPI 1700042520 · ANDERSON, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,652 in 97 payments from 20 companies in 2025. Trend: 2023 $1,887 · 2024 $1,451 · 2025 $1,652
Food & beverage: $1,652
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 19 | $317 |
| Ardelyx, Inc. | 15 | $199 |
| Janssen Biotech, Inc. | 13 | $161 |
| Ipsen Biopharmaceuticals, Inc | 5 | $129 |
| Phathom Pharmaceuticals, Inc. | 9 | $124 |
| GENZYME CORPORATION | 4 | $88 |
| Organon LLC | 4 | $79 |
| PFIZER INC. | 4 | $77 |
| Gilead Sciences, Inc. | 3 | $62 |
| Intercept Pharmaceuticals, Inc. | 3 | $53 |
Products named: IBSRELA, MAVYRET, TREMFYA, DUPIXENT, IQIRVO, VOQUEZNA, HADLIMA, SKYRIZI.
Industry payments across SC — which companies pay providers there.
